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Abstract: Multiple factors control the expression of the outer membrane porins OmpF and
OmpC in Escherichia coli. In this work, we investigated the role of the mar-sox-rob regulon
in regulating outer membrane porin expression in response to salicylate. We provide both
genetic and physiological evidence that MarA and Rob can independently activate micF
transcription in response to salicylate, leading to reduced OmpF expression. MarA was
also found to repress OmpF expression through a MicF-independent pathway. In the case
of OmpC, we found that its transcription was moderately increased in response to
salicylate. However, this increase was independent of MarA and Rob. Finally, we found
that the reduction in OmpF expression in a tolC mutant is due primarily to Rob.
Collectively, this work further clarifies the coordinated role of MarA and Rob in regulating
the expression of the outer membrane porins.
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Gram-negative bacteria can limit the uptake of membraneimpermeable
antimicrobial compounds by modulating the composition of pores in their outer
membranes (44). In Escherichia coli and closely related organisms, this alteration
is accomplished in part by changing the relative expression of two porins, OmpF
and OmpC (17, 44, 46). Both OmpF and OmpC form structurally similar outer
membrane pores comprising trimers of 16-stranded -barrels (2, 13). However, the
two have different substrate specificities and diffusion rates (2, 13). The OmpF
porin, which forms the larger pore, permits the diffusion of molecules at
comparatively faster rates than OmpC (13).
The OmpF/OmpC ratio is primarily regulated at the transcriptional level by the
EnvZ-OmpR two-component system in response to changes in the osmolarity of
the growth medium (20, 26, 53, 55, 56). Numerous other factors also converge to
transcriptionally regulate the differential expression of ompF and ompC in response
to environmental conditions such as temperature and nutrient limitation (17, 46).
Apart from transcriptional regulation, OmpF and OmpC are also translationally
regulated through the action of two small regulatory RNAs (sRNA), MicF and MicC.
These sRNA molecules, when expressed, are known to bind to the 5 untranslated
regions (5-UTR) of ompF and ompC mRNAs and stop translation by preventing the
ribosome from binding (7, 39). Although MicC is known to interact with the ompC
mRNA, its expression is cryptic and has not been observed to substantially
influence OmpC expression (7). MicF, on the other hand, is known to be a
significant regulator of OmpF expression under certain environmental conditions,
and the regulation of its expression has been extensively investigated (1, 14, 18,
49).
MicF expression is regulated by multiple factors. These include not only OmpR
but also global transcription factors such as H-NS, Lrp, and IHF (16, 19, 27). In
addition, MicF expression is regulated by three homologous AraC/XylS family
transcription factors—MarA, SoxS, and Rob—when E. coli exhibits the porindependent antibiotic resistance phenotype (22, 29, 31, 34). These three
transcription factors are the master regulators of the extensive mar-sox-rob
regulon, involved in intrinsic multidrug resistance in enteric gammaproteobacteria
(34). The regulation of MarA and SoxS expression is chiefly mediated at the level
of transcription by the MarR repressor and SoxR redox sensor/activator,
respectively (11, 42, 58). Rob, on the other hand, is expressed constitutively and
regulated posttranslationally by a “sequestration-dispersion” mechanism (23, 29,
48, 50). Together, these three regulators control the expression of a number of
downstream, overlapping target genes involved in intrinsic multidrug resistance.
In this work, we investigated the regulation of OmpF and OmpC expression by
the mar-sox-rob regulon in response to the canonical inducer salicylate. We first
provide both genetic and physiological evidence that the reductions in the levels of
OmpF during salicylate exposure are through the parallel action of MarA and Rob
in increasing micF transcription. We also demonstrate that MarA regulates ompF

translation through a MicF-independent pathway. Finally, we found that the
reduced levels of OmpF expression (and correlated increases in OmpC
expression) in the absence of the TolC outer membrane efflux pore are primarily
due to the action of Rob activating micF transcription.
MATERIALS AND METHODS
Bacterial strains, media, and growth conditions. All strains used in this work are
listed in Table 1. Luria-Bertani liquid and solid media (10 g/liter tryptone, 5 g/liter
yeast extract, 10 g/liter NaCl) were used for routine bacterial culture and genetic
manipulation. Experiments were conducted in medium A (7 g/liter nutrient broth, 1
g/liter yeast extract, 2 g/liter glycerol, 3.7 g/liter K2HPO4, 1.3 g/liter KH2PO4) (28,
36). All bacterial cultures were grown at 37°C except for strains containing
plasmids pKD46, pINT-ts, and pCP20, which were grown at 30°C. Antibiotics were
used at the following concentrations: ampicillin, 100 g/ml; kanamycin, 20 g/ml; and
chloramphenicol, 20 g/ml. For some experiments,
TABLE 1. Bacterial strains and plasmids used in this work
Strain or plasmid

Strains
MG1655
BW25141

Genotype or relevant characteristicsa

MDG147

F λ ilvG rph-1
F- λ- Δ(araB-araD)567 ΔlacZ4787(::rrnB-3) Δ(phoBphoR)580 galU95 ΔuidA3::pir+ recA1 ΔendA9::FRTc
rph-1 Δ(rhaB-rhaD)568 hsdR514
MG1655 Φ(ompF+ -yfp+)30 Φ(ompC+-cfp+)31

CR701
CR702
CR713
CR714
CR715
CR716
CR717
CR718
CR719
CR720
CR721
CR722

ΔtolC::cat
ΔtolC::FRT
attλ::[kan ompF’-yfp oriR6K]
attλ::[kan ompF’-‘yfp(hyb) oriR6K]
attλ::[kan micF’-yfp oriR6K]
ΔmarRAB::kan (1617077–1618231)
ΔsoxRS::kan (4275083–4275950)
Δrob::cat (4632554–4633393)
ΔmicF::kan (2311106–2311203)
ΔompR::cat (3533885–3534603)
ΔmarRAB::FRT
ΔsoxRS::FRT

-

-

Source
and/or
referenceb

CGSC
7740
CGSC
7635
M. D.
Goulian, 4
10
10

CR723
CR724
CR725
CR726
CR727
CR728
CR729
CR730
CR731
CR732
CR733
CR734
CR735
CR736
CR737
CR738
CR739
CR740
CR741
CR742
CR743
CR744
CR745
CR746
CR747
CR748
CR749
CR750
CR751
CR752
CR753
CR754
CR755
CR756
CR757
CR758

Δrob::FRT
ΔmicF::FRT
ΔmarRAB::FRT ΔsoxRS::FRT
ΔmarRAB::FRT Δrob::FRT
ΔsoxRS::FRT Δrob::FRT
ΔmarRAB::FRT ΔsoxRS::FRT Δrob::FRT
ΔmicF::FRT ΔmarRAB::FRT
ΔmicF::FRT Δrob::FRT
ΔmicF::FRT ΔmarRAB::FRT Δrob::FRT
ΔtolC::FRT ΔmarRAB::FRT
ΔtolC::FRT ΔsoxRS::FRT
ΔtolC::FRT Δrob::FRT
ΔtolC::FRT ΔmarRAB::FRT ΔsoxRS::FRT Δrob::FRT
ΔtolC::FRT ΔmicF::FRT
ΔmarRAB::FRT attλ::[kan ompF’-yfp oriR6K]
ΔsoxRS::FRT attλ::[kan ompF’-yfp oriR6K]
Δrob::FRT attλ::[kan ompF’-yfp oriR6K]
ΔmicF::FRT attλ::[kan ompF’-yfp oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT attλ::[kan ompF’-yfp oriR6K]
ΔmarRAB::FRT Δrob::FRT attλ::[kan ompF’-yfp oriR6K]
ΔsoxRS::FRT Δrob::FRT attλ::[kan ompF’-yfp oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT Δrob::FRT attλ::[kan ompF’-yfp
oriR6K]
ΔmicF::FRT ΔmarRAB::FRT attλ::[kan ompF’-yfp oriR6K]
ΔmicF::FRT Δrob::FRT attλ::[kan ompF’-yfp oriR6K]
ΔmicF::FRT ΔmarRAB::FRT Δrob::FRT attλ::[kan ompF’-yfp
oriR6K]
ΔtolC::FRT attλ::[kan ompF’-yfp oriR6K]
ΔtolC::FRT ΔmarRAB::FRT attλ::[kan ompF’-yfp oriR6K]
ΔtolC::FRT ΔsoxRS::FRT attλ::[kan ompF’-yfp oriR6K]
ΔtolC::FRT Δrob::FRT attλ::[kan ompF’-yfp oriR6K]
ΔtolC::FRT ΔmarRAB::FRT ΔsoxRS::FRT Δrob::FRT
attλ::[kan ompF’-yfp oriR6K]
ΔtolC::FRT ΔmicF::FRT attλ::[kan ompF’-yfp oriR6K]
ΔmarRAB::FRT attλ::[kan ompF’-‘yfp(hyb) oriR6K]
ΔsoxRS::FRT attλ::[kan ompF’-‘yfp(hyb) oriR6K]
Δrob::FRT attλ::[kan ompF’-‘yfp(hyb) oriR6K]
ΔmicF::FRT attλ::[kan ompF’-‘yfp(hyb) oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT attλ::[kan ompF’-‘yfp(hyb)
oriR6K]

CR759
CR760
CR761
CR762
CR763
CR764
CR765
CR766
CR767
CR768
CR769
CR770
CR771
CR772

ΔmarRAB::FRT Δrob::FRT attλ::[kan ompF’-‘yfp(hyb) oriR6K]
ΔsoxRS::FRT Δrob::FRT attλ::[kan ompF’-‘yfp(hyb) oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT Δrob::FRT attλ::[kan ompF’‘yfp(hyb) oriR6K]
ΔmicF::FRT ΔmarRAB::FRT attλ::[kan ompF’-‘yfp(hyb)
oriR6K]
ΔmicF::FRT Δrob::FRT attλ::[kan ompF’-‘yfp(hyb) oriR6K]
ΔmicF::FRT ΔmarRAB::FRT Δrob::FRT attλ::[kan ompF’‘yfp(hyb) oriR6K
ΔtolC::FRT attλ::[kan ompF’-‘yfp(hyb) oriR6K]
ΔtolC::FRT ΔmarRAB::FRT attλ::[kan ompF’-‘yfp(hyb) oriR6K]
ΔtolC::FRT ΔsoxRS::FRT attλ::[kan ompF’-‘yfp(hyb) oriR6K]
ΔtolC::FRT Δrob::FRT attλ::[kan ompF’-‘yfp(hyb) oriR6K]
ΔtolC::FRT ΔmarRAB::FRT ΔsoxRS::FRT Δrob::FRT
attλ::[kan ompF-yfp(hyb) oriR6K]
ΔtolC::FRT ΔmicF::FRT attλ::[kan ompF’-‘yfp(hyb) oriR6K]
ΔmarRAB::FRT attλ::[kan micF’-yfp oriR6K]
ΔsoxRS::FRT attλ::[kan micF’-yfp oriR6K]
TABLE 1—Continued

Strain or
plasmid

CR773
CR774
CR775
CR776
CR777
CR778
CR779
CR780
CR781
CR782
CR783
CR784
CR785
CR786
CR787

Genotype or relevant characteristicsa

Δrob::FRT attλ::[kan micF’-yfp oriR6K]
ΔmicF::FRT attλ::[kan micF’-yfp oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT attλ::[kan micF’-yfp oriR6K]
ΔmarRAB::FRT Δrob::FRT attλ::[kan micF’-yfp oriR6K]
ΔsoxRS::FRT Δrob::FRT attλ::[kan micF’-yfp oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT Δrob::FRT attλ::[kan micF’-yfp
oriR6K]
ΔmicF::FRT ΔmarRAB::FRT attλ::[kan micF’-yfp oriR6K]
ΔmicF::FRT Δrob::FRT attλ::[kan micF’-yfp oriR6K]
ΔmicF::FRT ΔmarRAB::FRT Δrob::FRT attλ::[kan micF’-yfp
oriR6K]
ΔtolC::FRT attλ::[kan micF’-yfp oriR6K]
ΔtolC::FRT ΔmarRAB::FRT attλ::[kan micF’-yfp oriR6K]
ΔtolC::FRT ΔsoxRS::FRT attλ::[kan micF’-yfp oriR6K]
ΔtolC::FRT Δrob::FRT att::[kan micF’-yfp oriR6K]
ΔtolC::FRT ΔmarRAB::FRT ΔsoxRS::FRT Δrob::FRT
attλ::[kan micF’-yfp oriR6K]
ΔtolC::FRT ΔmicF::FRT attλ::[kan micF’-yfp oriR6K]

Source
and/or
referenceb

CR788
CR789
CR790
Plasmids
pKD46
pCP20
pKD3
pKD4
pKD13
pBAD30
pMarA
pRob
pVenus
pVenusompF
pVenus-FY
pVenus-micF

MDG147 ΔmarRAB::kan
MDG147 Δrob::cat
MDG147 ΔmarRAB::kan Δrob::cat

bla PBAD gam bet exo pSC101 ori(ts)
bla cat cI857 PR’-flp pSC101 ori(ts)
bla rgnB FRT cat FRT oriR6K
bla rgnB FRT aph FRT oriR6K
bla rgnB FRT aph FRT oriR6K
bla araC PBAD p15A ori
pBAD30::RBS-marA
pBAD30::RBS-rob
kan MCS yfp(venus) t0 attλ oriR6K
kan MCS ompF’-yfp(venus) t0 attλ oriR6K

15
8
15
15
15
24

52

kan MCS ompF’-‘yfp(venus)(hyb) t0 attλ oriR6K
kan MCS micF’-yfp(venus) t0 attλ oriR6K

All strains are isogenic derivatives of E. coli K-12 strain MG1655. Numbers in parentheses indicate
deletion endpoints as determined using the MG1655 genome sequence.
b All strains and plasmids are from this work unless otherwise noted.
c FRT, FLP recombination target.
a

arabinose was supplied at 0.1% (wt/vol) and sodium salicylate (Sigma-Aldrich, St.
Louis, MO) was introduced into growth medium at 5 mM.
Strain and plasmid construction. All strains used in this work are isogenic
derivatives of the sequenced E. coli K-12 strain MG1655. The generalized
transducing phage P1vir was used in all genetic crosses according to standard
methods (57). Targeted gene deletions and subsequent marker removal were
made using the Red recombinase method of Datsenko and Wanner (15). Sitespecific integrations were made using the Int/CRIM method of Haldimann and
Wanner (25).
Deletion cassettes were generated with the plasmid templates pKD3, pKD4, and
pKD13 using standardized priming sites (15). The marRAB, soxRS, rob, micF, and
ompR deletion cassettes were generated by PCR using the primer pairs 5-CTT
GAA CCG ATT TAG CAA AAC GTG GCA TCG GTC AAT TCA TTG TAG GCT
GGA GCT GCT TCG-3 and 5-GGG AAG TTA ATA AGC CCC GAG ATG TCG
GGG CCA GAA CAA ACA TAT GAA TAT CCT CCT TAG-3, 5-AGC AAT TAC
CCG CGC GGG AGT TAA CGC GCG GGC AAT AAA ATG TAG GCT GGA GCT
GCT TCG-3 and 5-ACC GGA AAA CAA ACT AAA GCG CCC TTG TGG CGC TTT
AGT TCA TAT GAA TAT CCT CCT TAG-3, 5-CTC CCG CTT TGG CAT CTT CTG
CCG GGT AGT ATC GCT CAA TTG TAG GCT GGA GCT GCT TCG-3 and 5-CTC
TAC TAA GAA AAA AAC ACT GAA TGC TAA AAC AGC AAA ACA TAT GAA TAT

CCT CCT TAG-3, 5-TGT CAA AAC AAA ACC TTC ACT CGC AAC TAG AAT AAC
TCC CAT TCC GGG GAT CCG TCG ACC-3 and 5-AGT TTT TCT GTG GTA GCA
CAG AAT AAT GAA AAG TGT GTA ATG TAG GCT GGA GCT GCT TCG-3, and
5-GCT TAC AAA TTG TTG CGA ACC TTT GGG AGT ACA AAC AAT GTG TAG
GCT GGA GCT GCT TCG-3 and 5-TAC GGG CAA ATG AAC TTC GTG GCG
AGA AGC GCA ATC GCC TCA TAT GAA TAT CCT CCT TAG-3, respectively. All
cassettes were transformed into MG1655 cells expressing Red recombinase from
the pKD46 helper plasmid. Deletions were verified by PCR using primers in the
antibiotic resistance marker and sites adjacent on the host chromosome. All
deletions were subsequently transduced into a clean MG1655 background prior to
antibiotic cassette removal using the FLP recombinase expressing pCP20 helper
plasmid.
Single-copy transcriptional and translational fusions were constructed in trans
using the pVenus integration vector (52). Transcriptional fusions to the PompF and
PmicF promoters were made by PCR amplifying the promoter regions of the ompF
and micF genes using primers 5-ATA GGT ACC ACG TGC TGG ACG AGC GTA
TG-3 and 5-ATA GAA TTC AGC AGG GAC GAT CAC TGC-3 and 5-ATA GGT
ACC ACC TGA GTT TCA CCT TTG AA-3 and 5-ATA GAA TTC TGC GAG GCA
TCC GGT TGA AA-3, respectively. Following amplification, the PCR products were
digested with KpnI and EcoRI (sequences underlined) and ligated into the
corresponding restriction sites of pVenus to produce pVenus-ompF and pVenusmicF. The translational fusion of ompF to yfp [ompF-yfp(hyb)] was produced in two
steps. First, a fragment containing the promoter region and the first 39 bases of
ompF was generated by PCR using primers 5-ATA GGT ACC ACG TGC TGG
ACG AGC GTA TG-3 and 5-CAG TGA AAA GTT CTT CTC CTT TAC TAG CAG
GGA CGA TCA CTG C-3. The resulting product also contained an overhang
complementary to 25 base pairs after the first 6 bases of yfp(venus). Second, the
ompF-yfp fragment was used to amplify the entire yfp(venus) and t0 terminator
region from pVenus using the reverse primer 5-CTC GCA ATC CAG TGC AAA-3.
The ompFyfp(hyb) fragment was then cloned into the KpnI (sequence underlined)
and NheI sites of pVenus to produce pVenus-FY. The pVenus derivatives
described above were then integrated into the phage λ attachment site in MG1655
cells expressing Int from the pINT-ts helper plasmid. Single-copy integrations were
verified by PCR using primers described by Haldimann and Wanner (25). Resulting
single-copy fusions were transduced back into a clean MG1655 background.
Complementation vectors for expression of MarA and Rob were constructed using
the medium-copy-number, arabinose-inducible pBAD30 plasmid (24). The marA
and rob genes were PCR amplified using forward and reverse primers 5-ATA GAA
TTC TTT ATA AGG AGG AAA AAC ATA TGA CGA TGT CCA GAC GC-3 and 5ATA TCT AGA CTA GCT GTT GTA ATG ATT TAA TGG A-3 and 5-ATA GAG CTC
TTT ATA AGG AGG AAA AAC ATA TGG ATC AGG CCG GCA TTA T-3 and 5ATA GGT ACC TTA ACG ACG GAT CGG AAT CA-3, respectively. The marA and

rob products both contain strong, synthetic ribosome binding sites (RBS) to ensure
high-level translation. Resulting PCR products were treated with EcoRI and XbaI
(sequences underlined) for marA and SacI and KpnI (sequences underlined) for
rob. The digested products were then ligated into the corresponding restriction
sites downstream of the PBAD promoter in pBAD30 to produce the plasmids pMarA
and pRob.
Fluorescence-based promoter activity assays. Cells were grown overnight in
medium A to saturation and subcultured 1:200 in fresh medium with or without 5
mM salicylate. For experiments, 0.5 ml was dispensed to individual wells of
microtiter plates with 96 deep, square wells (VWR; 82006-448). Plates were sealed
with Breath-Easy membranes (Diversified Biotech) to reduce evaporation, placed
on a high-speed, microplate shaker (VWR), and shaken at 1,000 rpm and 37°C.
To measure fluorescence and optical density (OD), 250 μl of culture was
transferred from the deep-well plates to black, clear-bottomed Costar 96-well
microtiter plates. Fluorescence (excitation/emission λ, 515/530 nm) and OD (600
nm) were measured using a Tecan Safire2 microplate reader. Fluorescence
measurements are reported as the relative fluorescence normalized to the optical
density of the sample to correct for differences in cell density. All experimental data
presented are the averages and standard deviations of four replicate samples.
Small-scale envelope preparation and SDS-PAGE. Envelope fractions were
prepared as described by Slauch and Silhavy with minor modifications (56). Briefly,
cells were grown overnight in medium A and subcultured 1:200 in 10 ml of fresh
medium with or without 5 mM salicylate. Cultures were grown to mid-log phase
(OD = 0.4 to 0.5). Sample volumes were normalized to the lowest optical density to
allow for comparison of outer membrane protein quantities across strain
backgrounds. Normalized cultures were then pelleted at 3,800 x g. The pellet was
washed once in 30 mM Tris-HCl (pH 8.1) and repelleted. Cell pellets were then
resuspended in 30 mM Tris-HCl–20% sucrose buffer, followed by the addition of 10
μl of 20-mg/ml lysozyme–0.1 mM EDTA (pH 7.3) and incubated on ice for 30 min.
Following lysozyme treatment, 3 ml of 3 mM ETDA (pH 7.3) was added and the
resulting extract was disrupted with a single 20-s pulse using a microtip sonicator
(Fisher Scientific). A 1.5-ml fraction of the extract was then centrifuged at 16,000 x
g for 60 min. Envelope fractions were collected as centrifuged precipitate and
resuspended in 40 μl of Laemmli SDS sample buffer (30). Samples were boiled at
100°C for 5 min prior to SDS-PAGE display. Finally, 10-μl aliquots were displayed
on 10% acrylamide–6 M urea-1% SDS gels at 150 V for 80 min.
RESULTS
Salicylate decreases the expression of OmpF and increases the expression of
OmpC. Previous reports have shown that exposure to salicylate decreases the

amount of OmpF in the outer membrane (12, 47, 49, 54). Although these reports all
observe a reduction in OmpF, discrepancies exist regarding changes in the
expression of OmpC. To determine the effects of salicylate on OmpF/OmpC
expression, we harvested insoluble membrane fractions from cells grown in a rich,
low-osmolarity medium (28) in the presence or absence of 5 mM salicylate (Fig. 1).
Under these conditions, we observed a decrease in the levels of OmpF and an
increase in the levels of OmpC in the outer membrane.
Most likely, these discrepancies between our work and those in the literature
regarding OmpC are due to differences in the strains employed. In our
experiments, we used strain MG1655. In those involving strain MC4100, salicylate
was found to decrease OmpC despite increases in ompC transcription (49).
However, in derivatives of strain AG100, no changes in OmpC expression were
observed (12).

FIG. 1. The levels of OmpC, OmpF, and OmpA in the outer membrane in the presence or absence
of salicylate. Cells were grown overnight in medium A and subcultured 1:200 in fresh medium A in
the presence or absence of 5 mM salicylate (SAL). OmpC, OmpF, and OmpA protein bands are
indicated. Strains used in this experiment were MG1655 and CR720.

We additionally explored the effects of OmpR on regulating OmpF/OmpC
expression under salicylate exposure (Fig. 1). Consistent with the observations of
Rosner and coworkers (49), both OmpF and OmpC are not expressed in the
absence of OmpR, irrespective of whether salicylate is present or not.
MarA and Rob are functionally redundant regulators of MicF and OmpF
expression. The MicF sRNA is known to repress the expression of OmpF. The
transcription of micF, in turn, is activated by MarA, SoxS, and Rob. Of the three,
only MarA expression is known to be directly responsive to salicylate (12, 33, 35).
However, Cohen and coworkers found that the reduction of OmpF expression in
response to salicylate was not solely dependent on increased expression of MarA
(12). Based on this observation, we hypothesized that Rob may also be involved.
Specifically, we have observed that Rob is indirectly activated by salicylate,
independent of either MarA or MarR (9). To test this hypothesis, we measured the
expression from single-copy transcriptional fusions of ompF and micF and a
translational fusion of OmpF to the fast-folding yellow fluorescing protein (YFP)
variant Venus (41). We performed these experiments in a series of genetic
backgrounds where the marRAB, soxRS, and rob regulatory components of the

FIG. 2. Full repression of ompF translation during salicylate exposure requires both MarA and Rob.
(A) Levels of ompF-yfp translation. (B) Transcriptional activity of the PompF promoter. (C)
Transcriptional activity of the PmicF promoter. Cells were grown overnight in medium A and
subcultured 1:200 in medium A containing 5 mM salicylate for 4 h prior to fluorescence and optical
density measurements. Presence or absence of genes is denoted by + or -, respectively. Strains
used in this experiment were CR713 to CR715, CR737 to CR744, CR754 to CR761, and CR771 to
CR778. (D) Transcriptional activity of PmicF and levels of ompF-yfp translation during ectopic
complementation of MarA and Rob in the presence and absence of MicF. Cells were grown in
medium A overnight and subcultured 1:200 in fresh medium A with and without 0.1% arabinose.
Strains used in this experiment are CR715, CR774, CR776, CR781, CR714, CR757, CR759, and
CR764.

marsox-rob network were systematically deleted. In addition, we tested the
expression of these fusions in a strain lacking micF. Consistent with our
hypothesis, we found that both MarA and Rob work in parallel to decrease OmpF
expression in the presence of 5 mM salicylate (Fig. 2A and 3). We also found that
MarA and Rob both increase ompF transcription (Fig. 2B). No change, however,
was observed upon loss of SoxS under identical conditions. Specifically, we
observed a 2.5-fold increase in OmpF expression, as determined using
translational fusions to Venus upon loss of either MarA (marRAB) or Rob (rob) (Fig.
2A). Likewise, we observed a 20% reduction in ompF transcription upon loss of
either transcription factor (Fig. 2B). Moreover, their contributions were additive with
respect to both OmpF expression and ompF transcription. The increases in OmpF
expression upon loss of either factor were also reflected by the changes in micF

transcription, where we found that the loss of MarA or Rob decreased transcription
1.4- or 2.1-fold, respectively (Fig. 2C). In mutants lacking both MarA and Rob, we
found that OmpF expression was increased greater than 6-fold, with correlated
decreases in micF transcription of greater than 26-fold.
We also measured OmpF expression in mutants lacking micF in the presence of
5 mM salicylate. Given the current regulatory model, disruptions in micF should
result in levels of OmpF translation comparable to those observed in a marRAB rob
double mutant or marRAB soxRS rob triple mutant. Surprisingly, we found that the
double and triple mutants exhibited 2-fold-higher levels of OmpF expression than
the micF mutant (Fig. 2A). These results demonstrate that MarA and Rob do not
regulate ompF translation in response to salicylate solely through a MicFdependent pathway. This conclusion is further supported by the phenotypic
observation that OmpF

FIG. 3. Both MarA and Rob are required to fully repress OmpF expression in the outer membrane
during salicylate exposure. Presence or absence of genes is indicated by + and -, respectively.
Cells were grown overnight in medium A and subcultured 1:200 in fresh medium A containing 5 mM
salicylate. Cultures were grown to mid-logarithmic phase prior to envelope extraction. Envelope
fractions were displayed on 10% acrylamide–6 M urea-1% SDS gels and stained with Coomassie
R250. Strains used were MG1655 and CR721 to CR728.

levels in the presence of 5 mM salicylate are higher in mutants lacking both MarA
and Rob than in mutants lacking MicF alone (Fig. 3).
Interestingly, we found that ompF transcription was reduced in a micF mutant in
the presence of salicylate (Fig. 2B), opposite to what we see at the levels of
translation and protein expression. Consistent with these results, the changes in
ompF transcription observed in a marRAB rob double mutant and a marRAB
soxRS rob triple mutant were nearly identical to those in a micF mutant. These
results are surprising, as Cohen and coworkers previously observed that increased
micF transcription decreases ompF transcription (12). One possible explanation is
that MicF stabilizes the mRNA of our OmpF transcriptional fusion. Regardless, we
suspect that the effect we observe is not physiologically significant.
The experiments described above were performed in the presence of 5 mM
salicylate. As a control, we also performed identical experiments in the absence of
salicylate. In this case, we found that both OmpF expression and ompF
transcription were mostly unchanged in the different mutant backgrounds (see Fig.
S1 in the supplemental material). The difference was no greater than 10% in the

case of the translational fusions and 20% in the case of the transcriptional fusions.
Likely, micF expression is too weak and OmpF expression too high for there

FIG. 4. MarA functions through MicF-dependent and MicF-independent pathways to reduce the
levels of OmpF during salicylate exposure. (A) Levels of ompF-yfp translation (strains CR757 and
CR762 to CR764). (B) Transcriptional activity of the PompF promoter (strains CR740 and CR745 to
CR747). (C) Transcriptional activity of the PmicF promoter (strains CR774 and CR779 to CR781). (D)
Levels of OmpC, OmpF, and OmpA in the envelope fraction displayed on a 10% acrylamide–6 M
urea-1% SDS gel (strains MG1655, CR724, and CR729 to CR731). Cells were grown in medium A
overnight and subcultured 1:200 in fresh medium A with 5 mM salicylate. Cultures were grown for 4
h prior to fluorescence and optical density measurements or to mid-log phase prior to envelope
extraction.

to be any change in the absence of salicylate. Indeed, micF expression is
significantly reduced in the absence of salicylate. One interesting observation,
though, is that OmpF expression is almost 2-fold higher in the absence of salicylate
in wild-type cells than in mutants in the presence of salicylate. These results
suggest that salicylate also represses OmpF expression through an alternate
mechanism.
We also tested whether MarA and Rob could independently repress OmpF
expression when ectopically expressed from an arabinose-inducible promoter on a
plasmid in the absence of salicylate (Fig. 2D). To account for different background
levels of OmpF expression, we also performed these experiments in the presence
of 200 mM NaCl (see Tables S1 and S2 in the supplemental material). In genetic
backgrounds containing micF, we found that the ectopic expression of MarA or Rob
led to a 10-fold increase in micF expression irrespective of whether NaCl was
present or not. This 10-fold increase correlates well with the corresponding 10-fold
decrease in OmpF expression that we also observed. In strains lacking micF, the
ectopic expression of MarA led to an approximately 50% reduction in OmpF
expression whereas the ectopic expression of Rob led to an approximately 30%

reduction in OmpF expression. While the level of repression is significantly
reduced, these results suggest, as discussed below, that MarA and possibly Rob
can repress OmpF expression independent of MicF.
MarA regulates OmpF expression through a MicF-independent pathway. We
observed that the ectopic expression of MarA or Rob could reduce OmpF
expression in a micF mutant (Fig. 2D), suggesting that the two may function
through a MicF-independent pathway. To further explore this putative mechanism,
we constructed marRAB and rob mutants in otherwise micF null genetic
backgrounds and monitored OmpF expression and ompF and micF transcription in
the presence of salicylate.
We found that loss of Rob had no effect on OmpF expression in the absence of
MicF (Fig. 4A and D), indicating that it functions upstream of MicF. In the case of
MarA, however, we found that deleting it could affect OmpF translation in the
absence of MicF. Specifically, we observed a 50% increase in OmpF expression
upon loss of MarA in an otherwise micF background (Fig. 4A and D), indicating that
MarA represses OmpF translation independent of MicF. Lastly, we found that the
decrease in micF transcription upon loss of MarA or Rob is independent of MicF
(Fig. 4C).
We also found that the decrease in ompF transcription upon loss of MarA or Rob
is due to MicF (Fig. 4B). In the absence of MicF, MarA or Rob had no effect on
ompF transcription. This epistasis indicates that both MarA and Rob function
upstream of MicF with regard to ompF transcription. It also suggests that MicF
activates ompF transcription, though this is likely an artifact of our transcriptional
fusions as discussed above.
Increases in ompC transcription are independent of MarA or Rob. Previous
results have shown increases in ompC transcription during salicylate exposure
(49). Despite the close proximity of the MarA/SoxS/Rob binding site in the
divergently arranged PmicF promoter, the role of MarA and Rob in mediating this
increase in ompC transcription has not been previously explored. To determine
whether the salicylate-induced increase in ompC transcription is MarA or Rob
dependent, we monitored ompC transcription in mutants lacking marRAB or rob
using a cyan fluorescing protein (CFP) gene fused downstream of the ompC
coding region. This fusion has previously been shown to have minimal effects on
OmpC expression and to provide an accurate measure of ompC transcription (3,
4). Consistent with the previous findings, we observed modest increases in ompC
transcription in the presence of 5 mM salicylate (Fig. 5). However, we found that
this in-

FIG. 5. Increases in ompC transcription are independent of MarA and Rob. Cells were grown
overnight in medium A and subcultured 1:200 in fresh medium A with or without 5 mM salicylate.
Cultures were grown for 4 h prior to fluorescence and optical density measurements. Strains used
in this experiment were MDG147 and CR788 to CR790.

crease is independent of MarA and Rob. These results indicate that MarA and Rob
do not regulate ompC transcription in response to salicylate.
The reduction in OmpF expression in tolC mutants is due to Rob. E. coli mutants
lacking TolC are known to have altered outer membrane porin compositions.
Specifically, the expression of OmpF in the outer membrane is significantly
reduced regardless of medium osmolarity (40). Misra and Reeves previously
showed that the reduction in OmpF expression in a tolC mutant was due to MicF
(38). However, they did not determine what caused micF transcription to increase
upon loss of TolC. Recent data from Rosner and Martin suggest that the increase
in micF transcription in tolC mutants is due to the upregulation of MarA, SoxS, and
Rob (51). Based on these findings, we wished to determine which of the mar-soxrob systems contribute to the decreased expression of OmpF observed in a tolC
mutant. Specifically, we studied the effects of MarA, SoxS, Rob, and MicF on the
expression of transcriptional and translational fusions described previously.
In the absence of tolC, we observed that OmpF expression

FIG. 7. MicF-dependent reduction of OmpF expression in tolC mutants is a result of Rob activation
of micF gene expression. Cells were grown overnight in medium A and subcultured 1:200 in fresh
medium A containing 5 mM salicylate. Cultures were grown to midlogarithmic phase prior to
envelope extraction. Envelope fractions were displayed on 10% acrylamide–6 M urea-1% SDS gels
and stained with Coomassie R250. Strains used were MG1655, CR702, and CR732 to CR736.

was decreased and micF transcription was increased, consistent with previous
findings (Fig. 6A and C). Introducing marRAB, soxRS, and rob deletions into the
tolC mutant background indicated that Rob is the primary, though not sole, factor
increasing micF transcription and, as a consequence, decreasing OmpF
expression (Fig. 6A and C). Examining OmpF expression in the outer membranes
of these mutants also supports this conclusion (Fig. 7). Collectively, these data
indicate that Rob is the primary regulator involved in increased MicF expression in
tolC mutants. The role of MarA and SoxS in this instance appears to be minor.
We also found that ompF transcription was increased in tolC mutants, though this
increase was rob and micF dependent (Fig. 6B). Specifically, we can attribute the
increase in ompF transcription to increased MicF expression through Rob. As we
have mentioned, increased MicF expression leads to increased ompF transcription,
though this effect is likely an artifact of our transcriptional reporter.
Though Rob is the key factor regulating MicF expression in a tolC mutant, these
findings do not directly indicate the source of Rob activation. Whether this is
caused by increased intracellular metabolites or perturbation of other elements of
cellular physiology is still unknown (10). Interestingly, MarA is upregulated in a tolC
mutant but does not affect MicF expression (51).

FIG. 6. Reduction in ompF translation by MicF in tolC mutants is a result of Rob-dependent
activation of micF gene expression. (A) Levels of ompF-yfp translation. (B) Transcriptional activity of
the PompF promoter. (C) Transcriptional activity of the PmicF promoter. Cells were grown overnight in
medium A and subcultured 1:200 in medium A containing 5 mM salicylate for 4 h prior to
fluorescence and optical density measurements. Strains used in this experiment were CR713 to
CR715, CR748 to CR753, CR765 to CR769, and CR782 to CR787.

DISCUSSION
In this work, we investigated the role of the mar-sox-rob regulon in regulating
outer porin expression, where the focus was on the MicF-dependent regulation of
OmpF expression upon salicylate exposure. We found that MarA and Rob can
independently activate micF transcription in response to salicylate, leading to
reduced OmpF expression. MarA was also found to repress OmpF expression

though a MicF-independent pathway. In the case of OmpC, salicylate increased its
transcription though this effect was independent of MarA and Rob. Finally, we were
able to show that the reduction in OmpF expression in a tolC mutant is due
primarily to Rob.
A key finding of this study was that MarA is not the sole factor regulating MicF
expression in response to salicylate. Rob is also capable of activating MicF
expression in response to salicylate. Both function in parallel regulatory pathways,
where their effects on OmpF expression are additive. Previous studies have, in
fact, shown that the salicylate-induced reduction in OmpF expression is not solely
due to MarA and that some other factor is involved (12). The surprising finding here
was that Rob is one of the factors. While salicylate is known to induce MarA
expression through the derepression of MarR and is often taken as the canonical
inducer for MarA, salicylate has not previously been shown to directly activate Rob
to the best our knowledge. The known activating ligands for Rob are bile salts, fatty
acids, and 2,2-dipyridyl (48, 50). Whether salicylate directly binds and activates
Rob, however, is unknown. We have found that MarA also activates a MicFindependent pathway to reduce OmpF expression. Rob can too but only when
ectopically expressed from a plasmid, a result not surprising given the common
binding targets for both regulators (5, 29, 34). These observations suggest that
MarA utilizes both MicF and the MicF-independent pathway simultaneously to
achieve levels of OmpF reduction similar to that which Rob accomplishes through
MicF alone. Through the combined action of these factors, the parallel MarA and
Rob-dependent pathways may serve to ensure OmpF reduction in the presence of
a variety of toxic chemicals.
How MarA is able to work through a MicF-independent pathway to inhibit
translation of ompF mRNA is unknown. As this regulation occurs at the level of
ompF translation, MarA likely regulates an additional sRNA not detected by
previous microarray analyses. Currently, the only well-characterized sRNA
regulator of ompF mRNA translation is MicF. Although our data suggest the
possibility of an additional sRNA regulator, they do not discount the possibility of
MarA-regulated factors that may work to destabilize the ompF mRNA. Future
implementation of sRNA detection strategies during salicylate exposure will help to
differentiate between these possibilities. OmpF expression is decreased in the
absence of the outer membrane efflux pore TolC (40). Misra and Reeves
previously demonstrated that this reduction in OmpF expression is due to MicF (37,
38). In the present study, we showed that the reduction in OmpF expression in the
absence of TolC is due primarily to Rob. These results are consistent with recent
observations made by Rosner and Martin, who have also shown that MarA and
SoxS expression and Rob activation are elevated approximately 2-fold in tolC null
mutants (51). The increase in mar-sox-rob regulon activation has been attributed in
part to the elevated intracellular levels of intermediary metabolites that serve as
inducers for these three systems (10, 51). What was surprising was that the tolC

effect could be almost solely ascribed to Rob even though the MarA expression is
also increased under these conditions.
Although this work has more clearly defined roles for MarA and Rob in regulating
OmpF expression in response to salicylate, there are still a number of unresolved
issues. For one, we found that ompC transcription is increased during salicylate
exposure in a MarA/Rob-independent manner. As the marsox-rob regulon is
extensive, it may be possible that additional downstream elements cause indirect
changes in the expression of ompC. Alternatively, parallel regulators responsive to
salicylate, such as EmrR (MprA), may instead regulate ompC transcription (32).
Another point of interest may be the convergence of additional two-component
systems at the ompF promoter that may be stimulated by salicylate and other
extracellular toxins. A number of systems, such as the CpxAR and RstAB twocomponent systems, have been shown to directly and indirectly change the activity
of the ompF promoter (4, 21, 43). Additionally, salicylate may stimulate other
extracytoplasmic stress systems. However, minimal overlap exists between
extracytoplasmic stress and salicylate transcriptional responses based on genomewide microarray data (6, 45). Whether MarA and Rob serve an auxiliary role in
changing the activity of these systems or EnvZ-OmpR activation remains to be
seen.
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